Skip to main content
SpringerLink
Log in

News from ASCO

  • Meeting report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Kroetz DL, Baldwin RM, Owzar K, Jiang C, Zembutsu H, Kubo M, Nakamura Y, Shulman LN, Ratain MJ, Cancer and Leukemia Group B.Inherited genetic variation in EPHA5, FGD4, and NRDG1 and paclitaxel (P)-induced peripheral neuropathy (PN): Results from a genome-wide association study (GWAS) in CALGB 40101. 46th Annual Meeting of the American Society of Clinical Oncology: abstr. 3021, 4 Jun 2010. Available from: URL: http://www.asco.org

  2. Spraggs CF, Budde LR, Briley LP, Bing N, Preston AJ, Mooser VE, Cardon LR, Stein SH.Relationship of HLA-DQA1*0201 and lapatinib-induced hepatotoxicity in women with advanced breast cancer. 46th Annual Meeting of the American Society of Clinical Oncology: abstr. 3100, 4 Jun 2010. Available from: URL: http://www.asco.org

  3. Mao J, Su I, Feng R, Desai K, Horn M, Chan D, Demichele A.Genetic variation in CYP19A1 and interleukin-6 and aromatase inhibitor-associated arthralgia in breast cancer survivors. 46th Annual Meeting of the American Society of Clinical Oncology: abstr. 526, 4 Jun 2010. Available from: URL: http://www.asco.org

  4. Levesque E, Bélanger A, Couture F, Jonker DJ, Villeneuve L, Harvey M, Guillemette C.The contribution of UGT1A and ABCB1 to irinotecan-induced toxicity: A prospective pharmacogenetic study of patients with metastatic colorectal cancer. 46th Annual Meeting of the American Society of Clinical Oncology: abstr. 3101, 4 Jun 2010. Available from: URL: http://www.asco.org

  5. Lee S, Won H, Son E, Lee J, Park S, Park J, Park Y, Lim H, Kang W.Genetic polymorphism associated with chronic neurotoxicity and recurrence in curatively-resected colon cancer patients receiving oxaliplatin-based adjuvant chemotherapy. 46th Annual Meeting of the American Society of Clinical Oncology: abstr. 3583, 4 Jun 2010. Available from: URL: http://www.asco.org

  6. Kim JJ, Vaziri SA, Elson P, Rini BI, Patel A, Basappa NS, Ganapathi M, Ganapathi R.Role of VEGF and VEGFR2 single nucleotide polymorphisms in predicting treatment-induced hypertension and clinical outcome in metastatic clear cell RCC patients treated with sunitinib. 46th Annual Meeting of the American Society of Clinical Oncology: abstr. 4629, 4 Jun 2010. Available from: URL: http://www.asco.org

  7. Loo DMT, Hagleitner MM, van Schie R, van der Sluis IM, Coenen MJ, Hoogerbrugge P.Genetic variants in MDR1 and CYP3A5 and vincristine toxicity in children with acute lymphoblastic leukemia. 46th Annual Meeting of the American Society of Clinical Oncology: abstr. 9526, 4 Jun 2010. Available from: URL: http://www.asco.org

  8. Kluetz PG, English BC, Baum CE, Sissung TM, Adelberg D, Dahut WL, Price DK, Figg WD.Evaluation of variants of the rs1934951 locus of CYP2C8 and bisphosphonate-related osteonecrosis of the jaw in castrate-resistant prostate cancer patients. 46th Annual Meeting of the American Society of Clinical Oncology: abstr. 9076, 4 Jun 2010. Available from: URL: http://www.asco.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

News from ASCO. React. Wkly. 1308, 6–7 (2010). https://doi.org/10.2165/00128415-201013080-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013080-00009

Keywords

Search

Navigation